Background Because of the advancement of bioabsorbable polymers and thinner struts,
bioabsorbable‐polymer sirolimus‐eluting stents (BP‐SES) with ultrathin struts may be …

Background Thin-strut biodegradable polymer sirolimus-eluting stents (BP-SES) have been
shown to reduce target lesion failure (TLF) at one-year follow-up compared with durable …

Objective The objective of this study was to assess the safety and efficacy of a polymer-free
sirolimus coated, ultrathin strut drug-eluting stent (PF-SES) in an unselected patient …

Objectives Determine whether an ultrathin biodegradable polymer sirolimus-eluting stent
('Orsiro'—BP-SES) has clinical benefits over second-generation durable polymer drug …

Background: Presentation with acute coronary syndromes (ACS) constitutes a high-risk
subset of patients with worse outcome after percutaneous coronary intervention. We report …

Background Newest generation drug-eluting stents combine biodegradable polymers with
ultrathin stent platforms in order to minimize vessel injury and inflammatory response …

In the Targeted therapy with a localised abluminal coated, low-dose sirolimus-eluting,
biodegreadable polymer coronary stent (TARGET; NCT02520180) All Comers trial the …

To date, there are few data regarding the comparison of the durable coating everolimus-
eluting stent (DP-EES) with the biodegradable polymer-coated sirolimus-eluting stent (BP …

Abstract Background The Orsiro biodegradable polymer sirolimus-eluting stent (O-SES) is a
new-generation biodegradable polymer drug-eluting stent with the thinnest strut thickness to …

Background No data are available on the long‐term performance of ultrathin strut
biodegradable polymer sirolimus‐eluting stents (BP‐SES). We reported 2‐year clinical …